161 related articles for article (PubMed ID: 8799516)
1. Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation.
Soedirman JR; De Bruijn EA; Maes RA; Hanck A; Grüter J
Br J Clin Pharmacol; 1996 Jun; 41(6):517-23. PubMed ID: 8799516
[TBL] [Abstract][Full Text] [Related]
2. VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.
Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J
Eur J Clin Pharmacol; 2013 Mar; 69(3):467-75. PubMed ID: 22864379
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone.
Schubiger G; Tönz O; Grüter J; Shearer MJ
J Pediatr Gastroenterol Nutr; 1993 May; 16(4):435-9. PubMed ID: 8315554
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis.
Amédée-Manesme O; Lambert WE; Alagille D; De Leenheer AP
J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):160-5. PubMed ID: 1593370
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability of phylloquinone from an intravenous lipid emulsion.
Camilo ME; Jatoi A; O'Brien M; Davidson K; Sokoll L; Sadowski JA; Mason JB
Am J Clin Nutr; 1998 Apr; 67(4):716-21. PubMed ID: 9537619
[TBL] [Abstract][Full Text] [Related]
6. The bioavailability of a mixed micellar preparation of vitamin K1, and its procoagulant effect in anticoagulated rabbits.
Winn MJ; White PM; Scott AK; Pratt SK; Park BK
J Pharm Pharmacol; 1989 Apr; 41(4):257-60. PubMed ID: 2568466
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous allergic reaction to intramuscular vitamin K1.
Wong DA; Freeman S
Australas J Dermatol; 1999 Aug; 40(3):147-52. PubMed ID: 10439527
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease.
Pereira SP; Rowbotham D; Fitt S; Shearer MJ; Wendon J; Williams R
J Hepatol; 2005 Mar; 42(3):365-70. PubMed ID: 15710219
[TBL] [Abstract][Full Text] [Related]
9. A stable isotope method for the simultaneous measurement of vitamin K1 (phylloquinone) kinetics and absorption.
Jones KS; Bluck LJ; Wang LY; Coward WA
Eur J Clin Nutr; 2008 Nov; 62(11):1273-81. PubMed ID: 17671443
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations after intravenous administration of phylloquinone (vitamin K(1)) in preterm and sick neonates.
Raith W; Fauler G; Pichler G; Muntean W
Thromb Res; 2000 Sep; 99(5):467-72. PubMed ID: 10973675
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis.
Hagstrom JN; Bovill EG; Soll RF; Davidson KW; Sadowski JA
Thromb Haemost; 1995 Dec; 74(6):1486-90. PubMed ID: 8772225
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.
Pereira SP; Shearer MJ; Williams R; Mieli-Vergani G
Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F113-8. PubMed ID: 12598499
[TBL] [Abstract][Full Text] [Related]
13. Plasma lipoproteins as carriers of phylloquinone (vitamin K1) in humans.
Lamon-Fava S; Sadowski JA; Davidson KW; O'Brien ME; McNamara JR; Schaefer EJ
Am J Clin Nutr; 1998 Jun; 67(6):1226-31. PubMed ID: 9625097
[TBL] [Abstract][Full Text] [Related]
14. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor EL-solubilized preparations of vitamin K1 to normal breast-fed newborns.
Schubiger G; Grüter J; Shearer MJ
J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):280-4. PubMed ID: 9138173
[TBL] [Abstract][Full Text] [Related]
15. Neonatal plasma vitamin K1 levels following oral and intramuscular administration of vitamin K1.
Gupta JM; Salonikas C; Naidoo D
Acta Paediatr; 1994 Feb; 83(2):133-4. PubMed ID: 8193487
[TBL] [Abstract][Full Text] [Related]
16. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.
Schubiger G; Stocker C; Bänziger O; Laubscher B; Zimmermann H
Eur J Pediatr; 1999 Jul; 158(7):599-602. PubMed ID: 10412823
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K absorption and kinetics in human subjects after consumption of 13C-labelled phylloquinone from kale.
Novotny JA; Kurilich AC; Britz SJ; Baer DJ; Clevidence BA
Br J Nutr; 2010 Sep; 104(6):858-62. PubMed ID: 20420753
[TBL] [Abstract][Full Text] [Related]
18. [Vitamin K 1 concentration and vitamin K-dependent clotting factors in newborn infants after intramuscular and oral administration of vitamin K 1].
Goldschmidt B; Kisrákói C; Téglás E; Verbényi M; Kovács I
Orv Hetil; 1990 Jun; 131(24):1297-300. PubMed ID: 2195426
[TBL] [Abstract][Full Text] [Related]
19. Changes of phylloquinone and menaquinone-4 concentrations in rat liver after oral, intravenous and intraperitoneal administration.
Sakamoto N; Kimura M; Hiraike H; Itokawa Y
Int J Vitam Nutr Res; 1996; 66(4):322-8. PubMed ID: 8979160
[TBL] [Abstract][Full Text] [Related]
20. Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake.
Olson RE; Chao J; Graham D; Bates MW; Lewis JH
Br J Nutr; 2002 Jun; 87(6):543-53. PubMed ID: 12067424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
